Gingi-aid Solution
Product Images NDC 10129-017

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Gingi-aid Solution (NDC 10129-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Active Ingredient (Active Ingredient)

This is a product that contains 25% by weight of the active ingredient aluminum chloride. Further information about the product, such as its intended use or form, is not available from the given text.*

FDA Label Image

Contraindications (Contraindications)

This text is a warning stating that the use of aluminum chloride is contraindicated in patients with a known history of hypersensitivity to it.*

FDA Label Image

Direction (Direction)

Gingi-Aid solution is a product that is intended to be used at room temperature. It should be applied with cotton pellets, a sponge, or a syringe with tips. One of the potential applications for Gingi-Aid is to soak it into an un-medicated retraction cord or braid, which can then be packed into the gingival area.*

FDA Label Image

Inactive Ingredients (Inactive Ingredients)

This is a list of inactive ingredients commonly found in a medication or other pharmaceutical product. It includes purified water, chlorobutanol, and sodium bicarbonate. These ingredients do not provide any therapeutic effect but may be necessary for formulation or as preservatives.*

FDA Label Image

Keep Out Of Reach Of Children (Keep Out Of Children)

This is a warning label advising to keep a certain product or item away from the reach of children.*

FDA Label Image

Precaution (Precautions)

This text is a set of precautions for a topical product. It advises to stop using it if any irritation appears and warns to avoid contact with eyes.*

FDA Label Image

Principal Display 15ml

This text is a description of a product called "Gingi-AID® NDC 10129-017-02 Epinephrine-Free". It contains "Aluminum Chorde-6+ycrate", an aqueous vehicle with buffering agents, and a 25% solution of aluminum chloride. It is a topical hemostatic solution and is manufactured by GingiPak. The address of the manufacturer is given as 4825 Callo Alto, Camarillo, CA 93011 USA.*

FDA Label Image

Principal Display 40ml

This appears to be a product description for a topical hemostatic solution called "Gingi-Pak" manufactured by Gingi-Pak company located at 4825 Calle Alto, Camarillo, CA 93011 USA. The solution is called "Epinephrine-Free" and contains 25% aluminum chloride-6-hydrate in an aqueous vehicle with buffering. The text also includes translations of the product name and aluminum chloride solution in several languages.*

FDA Label Image

Purpose (Purpose)

FDA Label Image

Storage (Storage)

This text is a warning message advising to avoid exposing something to temperatures exceeding 40°C (104°F).*

FDA Label Image

Uses (Uses)

This text describes the various dental procedures in which a hemostatic agent called "Uses" can be used to control bleeding or for topical hemostasis. It can be used in implantation, root canals, gingivectomy, frenectomy, tissue retraction, oral surgery, and crown and bridge preparations.*

FDA Label Image

Warnings (Warnings)

This text is a set of warnings for a product, most likely a topical application that contains aluminum chloride. It states that the product is intended for external use only and should not come into contact with eyes. It should also not be used if the patient has a known hypersensitivity to aluminum chloride. Any irritation should prompt the user to stop using the product and consult a doctor. Finally, the text advises keeping the product out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.